JP5568463B2 - 生体内で細胞および組織の生存を促進するための酸素生成組成物 - Google Patents

生体内で細胞および組織の生存を促進するための酸素生成組成物 Download PDF

Info

Publication number
JP5568463B2
JP5568463B2 JP2010503028A JP2010503028A JP5568463B2 JP 5568463 B2 JP5568463 B2 JP 5568463B2 JP 2010503028 A JP2010503028 A JP 2010503028A JP 2010503028 A JP2010503028 A JP 2010503028A JP 5568463 B2 JP5568463 B2 JP 5568463B2
Authority
JP
Japan
Prior art keywords
tissue
composition
therapeutic agent
oxygen
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010503028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523661A5 (enExample
JP2010523661A (ja
Inventor
ハリソン，ベンジャミン・エス
ヨー，ジェイムズ・ジェイ
アタラ，アンソニー
Original Assignee
ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ filed Critical ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ
Publication of JP2010523661A publication Critical patent/JP2010523661A/ja
Publication of JP2010523661A5 publication Critical patent/JP2010523661A5/ja
Application granted granted Critical
Publication of JP5568463B2 publication Critical patent/JP5568463B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Composite Materials (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2010503028A 2007-04-09 2008-04-08 生体内で細胞および組織の生存を促進するための酸素生成組成物 Expired - Fee Related JP5568463B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91068607P 2007-04-09 2007-04-09
US60/910,686 2007-04-09
PCT/US2008/004502 WO2008124126A1 (en) 2007-04-09 2008-04-08 Oxygen-generating compositions for enhancing cell and tissue survival in vivo

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014075396A Division JP5926758B2 (ja) 2007-04-09 2014-04-01 生体内で細胞および組織の生存を促進するための酸素生成組成物

Publications (3)

Publication Number Publication Date
JP2010523661A JP2010523661A (ja) 2010-07-15
JP2010523661A5 JP2010523661A5 (enExample) 2011-08-18
JP5568463B2 true JP5568463B2 (ja) 2014-08-06

Family

ID=39831273

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010503028A Expired - Fee Related JP5568463B2 (ja) 2007-04-09 2008-04-08 生体内で細胞および組織の生存を促進するための酸素生成組成物
JP2014075396A Expired - Fee Related JP5926758B2 (ja) 2007-04-09 2014-04-01 生体内で細胞および組織の生存を促進するための酸素生成組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014075396A Expired - Fee Related JP5926758B2 (ja) 2007-04-09 2014-04-01 生体内で細胞および組織の生存を促進するための酸素生成組成物

Country Status (6)

Country Link
US (3) US10493040B2 (enExample)
EP (1) EP2155235B1 (enExample)
JP (2) JP5568463B2 (enExample)
AU (1) AU2008236622B2 (enExample)
CA (1) CA2682507C (enExample)
WO (1) WO2008124126A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008236622B2 (en) * 2007-04-09 2013-01-10 Wake Forest University Health Sciences Oxygen-generating compositions for enhancing cell and tissue survival in vivo
WO2010011131A1 (en) * 2008-07-25 2010-01-28 Rijksuniversiteit Groningen Oxygen delivering scaffold for tissue engineering
US8986725B2 (en) * 2009-04-15 2015-03-24 University Of Miami Silicone-peroxide compositions for long-term, controlled oxygen release
EP2521587B1 (en) 2010-01-08 2020-04-08 Wake Forest University Health Sciences Delivery system
TWI405804B (zh) * 2010-04-19 2013-08-21 Geonano Environmental Technology Inc 高分子複合釋氣物質控制載體及其製造方法
AU2011293344B2 (en) * 2010-08-25 2015-07-30 Medtronic, Inc. Novel medical device coatings
EP2683328B1 (en) 2011-03-07 2017-11-08 Wake Forest University Health Sciences Delivery system
US9181093B2 (en) 2011-07-29 2015-11-10 Avent, Inc. Two part oxygen generating system
US8652531B2 (en) 2011-07-29 2014-02-18 Kimberly-Clark Worldwide, Inc. Indicator for oxygen generation
US9393272B2 (en) 2011-08-09 2016-07-19 Wake Forest University Health Sciences Co-encapsulation of live cells with oxygen-generating particles
US20140294944A1 (en) * 2013-03-28 2014-10-02 Kimberly-Clark Worldwide, Inc. Microencapsulation of oxygen liberating reactants
US20190060529A9 (en) * 2013-05-28 2019-02-28 The Johns Hopkins University Oxygen-charged implantable medical devices for and methods of local delivery of oxygen via outgassing
US11464831B2 (en) 2015-01-05 2022-10-11 Cornell University Compositions and methods using IL-8 for improving health of mammals
MX391211B (es) 2015-01-05 2025-03-21 Univ Cornell Composiciones y metodos que usan il-8 para mejorar produccion de leche y salud reproductiva en mamiferos.
EP3328458B1 (en) 2015-07-29 2020-05-06 Innovative Therapies Inc. Wound therapy device pressure monitoring and control system
WO2017039435A1 (en) * 2015-08-28 2017-03-09 Rijksuniversiteit Groningen Means and methods for sustained oxygen release in situ
CN106860032B (zh) * 2016-10-25 2021-04-09 咏达生医材料股份有限公司 一种气态皮肤供氧美白产品及其应用
GB201707153D0 (en) 2017-05-04 2017-06-21 Univ Ulster Therapy
WO2020040783A1 (en) * 2018-08-24 2020-02-27 Avent, Inc. Polyurethanes as oxygen delivery carriers
EP3646893A1 (en) 2018-10-29 2020-05-06 Solvay Sa Solid spray composition
WO2021113018A1 (en) * 2019-12-02 2021-06-10 University Of Florida Research Foundation Oxygen generating and free radical scavenging biomaterial
WO2021122707A1 (en) 2019-12-19 2021-06-24 Solvay Sa Oxygen generating composition
KR102385533B1 (ko) * 2020-03-03 2022-04-11 인하대학교 산학협력단 산소 발생 상처 피복재 및 이의 제조 방법
US20240374779A1 (en) * 2021-04-15 2024-11-14 Terasaki Institute For Biomedical Innovation Antimicrobial articles, methods of making and using same
WO2024030418A2 (en) * 2022-08-02 2024-02-08 The Secant Group, Llc Biodegradable, elastomeric anastomotic tissue junction stabilizer

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839220A (en) * 1968-10-23 1974-10-01 Mennen Co Microcapsules for use in pressurized systems
US3996141A (en) * 1971-10-22 1976-12-07 Wisconsin Alumni Research Foundation Dialysis membrane
JPS53960B2 (enExample) * 1974-03-23 1978-01-13
US4411872A (en) * 1977-03-07 1983-10-25 Bramson Mogens L Water unit for use with a membrane blood oxygenator
GB2024012B (en) * 1978-04-10 1982-07-28 Johnson & Johnson Oxygen-generating surgical dressing
DE3031485A1 (de) 1980-01-08 1982-07-08 Wilhelm 4950 Minden Scheidler Mittel zur auflockerung und regenerierung des naehrbodens von pflanzen, sowie zur aktivierung und stimulierung von pflanzennahrung
FR2513119A1 (fr) * 1981-09-18 1983-03-25 Dentalphy Ste Civile Produit de recouvrement et de protection de la surface de plaies superficielles
DE3213389A1 (de) * 1982-04-10 1983-10-20 Friedrich-Wilhelm Dr. 7107 Neckarsulm Kühne Stabilisierter aktivierter sauerstoff und arzneimittel, die diesen stabilisierten aktivierten sauerstoff enthalten
EP0227955A3 (en) * 1982-07-21 1987-11-25 University of Strathclyde Composite wound dressing
JPS60261600A (ja) 1984-06-07 1985-12-24 Sumitomo Cement Co Ltd 底質改良組成物及び工法
JPS61202639A (ja) * 1985-03-07 1986-09-08 三菱化学株式会社 漁網
US4623536A (en) 1985-06-13 1986-11-18 Church & Dwight Co., Inc. Sodium bicarbonate containing toothpaste
US5407685A (en) * 1986-02-06 1995-04-18 Steris Corporation Controlled oxygen/anti-microbial release films
SE464850B (sv) * 1989-07-19 1991-06-24 Ellem Bioteknik Ab Saett foer preparering av en implantatkropp genom behandling med en vaeteperoxidloesning
US5045296A (en) * 1989-10-30 1991-09-03 Fmc Corporation Sodium carbonate perhydrate process
US4976955A (en) * 1989-11-20 1990-12-11 Libin Barry M Oral hygiene composition
JP3191817B2 (ja) * 1991-02-26 2001-07-23 トピー実業株式会社 酸素発生剤
EP0623552B1 (en) * 1993-05-06 1998-01-07 Mitsubishi Gas Chemical Company, Inc. Process for producing hydrogen peroxide
EP1031928B1 (en) * 1993-06-04 2005-05-18 Network Appliance, Inc. A method for providing parity in a raid sub-system using non-volatile memory
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
US5792090A (en) * 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
US6552162B1 (en) * 1997-07-31 2003-04-22 Kimberly-Clark Worldwide, Inc. Water-responsive, biodegradable compositions and films and articles comprising a blend of polylactide and polyvinyl alcohol and methods for making the same
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
DE19831798A1 (de) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Mittel zur Pflege und/oder Behandlung von Haut und Gewebe
US6346228B1 (en) * 1999-02-19 2002-02-12 Council Of Scientific And Industrial Research Hydrophobic multicomponent catalyst useful for direct oxidation of hydrogen to hydrogen peroxide
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
JP2001064433A (ja) * 1999-08-31 2001-03-13 Dainippon Ink & Chem Inc ポリエステル多孔膜の製造方法
US6592890B1 (en) * 1999-10-20 2003-07-15 Oxibio, Inc. Conveyance of anti-infective activity to wound dressings
US6579533B1 (en) * 1999-11-30 2003-06-17 Bioasborbable Concepts, Ltd. Bioabsorbable drug delivery system for local treatment and prevention of infections
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
DE60028415T2 (de) 1999-12-30 2007-06-06 Acrymed, Portland Methode und zusammensetzungen für verbesserte abgabevorrichtungen
US6969480B2 (en) 2000-05-12 2005-11-29 Matregen Corp. Method of producing structures using centrifugal forces
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US6565888B1 (en) 2000-08-23 2003-05-20 Alkermes Controlled Therapeutics, Inc. Methods and compositions for the targeted delivery of biologically active agents
US6767342B1 (en) * 2001-04-23 2004-07-27 Evelyna D. Cantwell Oxygen bandage system
CA2480141A1 (en) * 2002-03-28 2003-10-09 Exponential Biotherapies, Inc. Oxygenating agents for enhancing host responses to microbial infections
US20060142684A1 (en) 2003-04-11 2006-06-29 Shanbrom Technologies, Llc Oxygen releasing material
EP1628912A2 (de) * 2003-05-23 2006-03-01 Degussa AG Verwendung von pulverf rmigen mischungen, enthaltend wassers toffperoxid und hydrophobiertes siliciumdioxid zur kontrollierten freisetzung von wasserstoffperoxid oder sauerstoff
US7014630B2 (en) * 2003-06-18 2006-03-21 Oxyband Technologies, Inc. Tissue dressing having gas reservoir
US20050112363A1 (en) * 2003-11-21 2005-05-26 Xin Ning Biodegradable polymer compositions for a breathable film
US20050186260A1 (en) * 2004-02-19 2005-08-25 Narini Philip P. Medicated gel foam and method of use
US20050281890A1 (en) * 2004-06-18 2005-12-22 San Chandan K Methods and compositions for wound healing
JP5112872B2 (ja) * 2004-10-07 2013-01-09 エヌジーイーエヌ・ファーマソーティカルズ・エヌ．ブイ． 創傷および火傷を治療するための組成物
US20090076206A1 (en) 2005-04-05 2009-03-19 Stefano Gardi Additive Mixtures for Agricultural Articles
WO2007134304A1 (en) * 2006-05-15 2007-11-22 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
US20090324668A1 (en) * 2006-06-28 2009-12-31 Ilkka Kangasniemi Implant, its uses and methods for making it
AU2008236622B2 (en) * 2007-04-09 2013-01-10 Wake Forest University Health Sciences Oxygen-generating compositions for enhancing cell and tissue survival in vivo
WO2009102487A2 (en) * 2008-02-13 2009-08-20 Oxygen Biotherapeutics, Inc. Gas based wound and tissue therapeutics
WO2010011131A1 (en) * 2008-07-25 2010-01-28 Rijksuniversiteit Groningen Oxygen delivering scaffold for tissue engineering

Also Published As

Publication number Publication date
EP2155235B1 (en) 2016-04-06
WO2008124126A1 (en) 2008-10-16
CA2682507C (en) 2017-11-21
JP2014159438A (ja) 2014-09-04
US20190022021A1 (en) 2019-01-24
EP2155235A1 (en) 2010-02-24
US10493040B2 (en) 2019-12-03
AU2008236622B2 (en) 2013-01-10
US10493041B2 (en) 2019-12-03
US20200155474A1 (en) 2020-05-21
AU2008236622A1 (en) 2008-10-16
JP2010523661A (ja) 2010-07-15
US20100112087A1 (en) 2010-05-06
EP2155235A4 (en) 2011-10-26
JP5926758B2 (ja) 2016-05-25
CA2682507A1 (en) 2008-10-16
US11318106B2 (en) 2022-05-03

Similar Documents

Publication Publication Date Title
JP5568463B2 (ja) 生体内で細胞および組織の生存を促進するための酸素生成組成物
Stan et al. Wound healing applications of creams and “smart” hydrogels
Kong et al. Biomimetic hydrogel for rapid and scar-free healing of skin wounds inspired by the healing process of oral mucosa
Daristotle et al. Sprayable and biodegradable, intrinsically adhesive wound dressing with antimicrobial properties
US8697118B2 (en) Stabilizers for hemostatic products
JP6309033B2 (ja) 創傷の治癒
JP2002528407A (ja) 創傷治療用のミクロスフェアを含む組成物
US9402881B2 (en) Tissue regeneration and wound treatment methods with platelet derived compositions
CN101022816A (zh) 治愈伤口的方法及组合物
WO2008037262A1 (en) Wound healing composition comprising phosphate, iron and copper
Lee et al. Orodispersible hyaluronic acid film delivery for oral wound healing in rats
AU2013203151B2 (en) Oxygen-generating compositions for enhancing cell and tissue survival in vivo
US20230338296A1 (en) Devices and methods for delivery of oxygen to a wound
CN117582545A (zh) 一种宫腔修复材料及其制备方法和应用
EP2737895A1 (en) Microparticles with EGF, method of preparation and use
TWI742571B (zh) 生物材料及其用於促進組織再生的用途
US20220211683A1 (en) Novel material for skin wound closure and scar prevention
RO138005A2 (ro) Matrici polimerice adezive din componenţa pansamentelor pentru tratamentul plăgilor tip escare

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110408

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110630

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130131

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130208

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130507

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130520

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140401

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140404

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140430

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140523

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140623

R150 Certificate of patent or registration of utility model

Ref document number: 5568463

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees